Targeting telomerase: T-cell friendly fire.
In this issue of Blood, Ugel and colleagues provide evidence that, in murine models, telomerase is an efficient target for adoptive cell therapy against a variety of cancer cells, but also can elicit an autoimmune response against B cells.(1).
Calado
Rodrigo T
RT
National Institutes of Health, USA.